Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBIDS.L Regulatory News (BIDS)

  • There is currently no data for BIDS

Loan Extension

26 Nov 2014 07:00

RNS Number : 9969X
Fitbug Holdings PLC
26 November 2014
 



Fitbug Holdings Plc / Epic: FITB.L / Index: AIM / Sector: Leisure

26 November 2014

Fitbug Holdings plc ('Fitbug' or 'the Company')

Agreed extension of loans to mid-2016 strengthens balance sheet

 

Fitbug Holdings Plc, the AIM listed provider of online personal health and well-being services, is pleased to announce that it has agreed that the repayment date of all loans, totalling £6.94 million, to the Company from NW1 Investments Limited will be extended to 31 July 2016. Other terms remain unchanged including the interest rate which remains at 5%.

 

NW1 Investments Limited is a company in which the family of David Turner and Allan Fisher, both directors of Fitbug, have a material interest.

 

Fergus Kee, Chairman of Fitbug said, "We are pleased to have reached an agreement to extend the repayment date on our existing loans with NW1 Investments. It strengthens our balance sheet at an exciting time for Fitbug as we move to scale up the business to meet growing demand for wearable technology."

 

**ENDS**

For further information visit www.KiQplan.com or www.fitbugholdings.com contact:

 

Paul Landau/Andrew Brummer

Fitbug Holdings Plc

020 7449 1000

Mark Percy/Catherine Leftley

Cantor Fitzgerald Europe

020 7894 7000

Claire Louise Noyce

Hybridan LLP

0203 713 4580

Elisabeth Cowell/Charlotte Heap

St Brides Media & Finance Ltd

020 7236 1177

 

Notes

Fitbug is a leading provider of online health and well-being services to help individuals to improve their lifestyles by making realistic changes to their daily routine. It combines activity tracking devices, which download to the Fitbug app and fitbug.com to provide an understanding of each user's daily activity achievements, with mobile and web technology which provides users with personalised weekly activity and nutrition targets, feedback, advice and encouragement. Its "Kiqplan"TM digital health coaching platform is designed to make wearable technology relevant to new audiences and take the "so what?" out of activity tracking by providing structured action plans to help people get fitter, lighter and lead happier, healthier lives.

 

Key market sectors and distribution channels include retail, health insurance and rewards providers, workplace health programmes, fitness operators and consumers. Increasingly, Fitbug's platforms act as the driving force behind third party services such as white label sites, activity driven games and challenge microsites and rewards programmes. An important part of the Company's focus is on building strategic partnerships with organisations which can integrate Fitbug into their own service/product offerings or resell to their customer base. The Company has operations in the UK, Australia and Asia, with the United States remaining the primary market. For more information, visit www.fitbug.com and www.KiQplan.com.

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
AGRFEWEFIFLSEFF
Date   Source Headline
28th Oct 201412:03 pmRNSStatement re Share Price
22nd Oct 20147:00 amRNSFitbug to be stocked by Target and Sainsbury's
30th Sep 20147:00 amRNSInterim Results
29th Jul 20147:00 amRNSSecures £1,750,000 Loan on Attractive Terms
26th Jun 20147:00 amRNSResult of AGM
29th May 20147:00 amRNSFinal Results
30th Apr 201412:00 pmRNSLoan Update
23rd Apr 20147:00 amRNSAppointment of CEO & US Retail Representative
26th Mar 20147:00 amRNSAppointed Group Sales Director & 6 Retail Partners
11th Feb 20147:00 amRNSLaunch of Fitbug KiK Plan and £1,000,000 Loan
11th Dec 20137:00 amRNSSecures £1,000,000 Loan on Attractive Terms
21st Oct 20137:00 amRNSCommercial Launch of Fitbug Orb
20th Sep 20137:00 amRNSInterim Results
10th Sep 20137:00 amRNSEntry into Australian Market - MSA with Leap4Life
15th Aug 20137:00 amRNSEntry into Asian Markets - Launch of AIA Vitality
27th Jun 20133:30 pmRNSResult of AGM
20th Jun 20137:00 amRNSJoin leading US health insurer's CarePass Platform
31st May 20137:00 amRNSFinal Results and Notice of AGM
9th Apr 20137:00 amRNSSecures £750,000 Loan on Attractive Terms
12th Mar 201311:45 amRNSChange of Adviser
7th Mar 20137:00 amRNSSigns Partnership Deals with 3 Leading Businesses
28th Jan 20137:00 amRNSSecures £500,000 Loan on Attractive Terms
9th Jan 20137:00 amRNSLaunch 3 New Products at Consumer Electronic Show
27th Sep 20127:00 amRNSInterim Results
17th Sep 20127:00 amRNSLaunches Fitbug Air
16th Jul 20127:00 amRNSTwo New US Sales Worth US $500,000
2nd Jul 20127:00 amRNSIssue of Convertible Loan Note & Director Dealings
26th Jun 20123:45 pmRNSResult of AGM
15th Jun 20127:00 amRNSAppointment of Joint Broker
11th Jun 20127:00 amRNSLaunch of New Games Framework and iPhone App
31st May 20127:00 amRNSFinal Results and Notice of AGM
9th May 20127:00 amRNSAppointed Activity Tracking Partner in US
20th Mar 20127:00 amRNSGrowth in France and Launch of Product in Germany
20th Feb 20127:00 amRNSAgreement with Major US Health Insurer & Placing
21st Oct 20117:00 amRNSSigns Agreement With MeYou Health
3rd Oct 20117:00 amRNSThree Actions to Support and Accelerate US Growth
22nd Sep 20117:00 amRNSInterim Results
5th Sep 20117:00 amRNSAgreement with Leading US Health Insurer
20th Jul 20112:40 pmRNSResult of AGM
19th Jul 20117:00 amRNSPlacing to raise GBP770,000
27th Jun 20117:00 amRNSFinal Results and Notice of AGM
14th Jun 20117:00 amRNSFour New Deals
23rd May 20117:00 amRNSAgreement - S. Africa Private Medical Insurer
13th Apr 20117:00 amRNSGrant of Options & Conversion of Outstanding Debt
11th Apr 20117:00 amRNSAppointment of Executive Chairman
21st Mar 20117:00 amRNSHolding in Company & Directors' Interests
4th Feb 20117:00 amRNSAppointment of Joint Broker
9th Nov 20105:27 pmRNSHolding(s) in Company
19th Oct 20107:00 amRNSPlacing to raise ?600,000 and trading update
4th Oct 20107:00 amRNSStrategic Partnership with SCIFIT and Patterson

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.